ArticlePloS one2015

EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.

Dongsheng Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.